THERATECHNOLOGIES INC.

Analyst Reco. Theratechnologies Inc.

Equities

TH

CA88338H7040

Delayed Toronto S.E. Other stock markets 10:07:16 2024-04-30 EDT			5-day change	1st Jan Change
1.79 ^CAD	0.00%		-5.29%	-16.36%

04-10	Update On Theratechnologies; Down More Than 5% On TSX As Q1 Net Loss Narrows, Awaits FDA Decision	MT
04-10	Theratechnologies Up Near 6% In US Premarket As Q1 Net Loss Narrows, Accelerates Phase 1 Trial of Ovarian Cancer Drug	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JonesTrading Adjusts Price Target on Theratechnologies to $3 From $6, Maintains Buy Rating	23-07-17	MT
Toronto Stocks Advance as BoC Raises Interest Rates; Laurentian Bank Surges on Strategic Review Launch	23-07-12	DJ
Canaccord Assumes Theratechnologies at Hold With $2 Price Target	23-07-03	MT
Cantor Fitzgerald Starts Theratechnologies at Overweight With $9 Price Target	22-11-17	MT
National Bank Trims Theratechnologies' Price Target to $3.25, Maintains Sector Perform	22-07-15	MT
THERATECHNOLOGIES : Canaccord Genuity Downgrades Theratechnologies to Hold From Buy, Adjusts Price Target to $3 From $8	21-07-29	MT
THERATECHNOLOGIES : Canaccord Adjusts Theratechnologies' Price Target to $8 from $7, Keeps Buy Rating	21-04-19	MT
THERATECHNOLOGIES : RBC Capital Keeps Sector Perform, US$2 TP on Theratechnologies Says Prefers to Stay on Sidelines For Now	21-01-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer